Company Filing History:
Years Active: 2007
Title: Innovations in Breast Cancer Treatment: The Contributions of Ronald Reiter
Introduction
Ronald Reiter is a prominent inventor located in Sølzburg, Austria, known for his significant contributions to cancer research. His invention pertains to the diagnosis and treatment of breast cancer, showcasing the potential of tailored therapeutic approaches based on molecular biology.
Latest Patents
Ronald Reiter holds a patent that focuses on the AIB1 protein as a coactivator in the diagnosis and treatment of breast cancer. His research revealed that the gene encoding AIB1 is amplified in specific subsets of human breast cancers. One notable splice variant, termed Δ3-AIB1, produces a 130 kDa protein that possesses a distinct role in enhancing transcriptional activity. This protein is found in higher concentrations within MCF-7 breast cancer cells compared to normal mammary epithelial cells, emphasizing its relevance in cancer biology.
Career Highlights
Ronald Reiter has established himself as an influential figure in the field of breast cancer research. His innovative work demonstrates how the Δ3-AIB1 isoform significantly outperforms the full-length AIB1 in promoting transcription mediated by estrogen and progesterone receptors. Furthermore, it is shown to effectively enhance transcription induced by epidermal growth factor, indicating its critical role in sensitizing breast tumor cells to hormonal and growth factor stimulation.
Collaborations
Throughout his career, Ronald has collaborated with notable researchers, including Anna T. Riegel and Anton Wellstein. Together, they delve into the complexities of breast cancer at Georgetown University, contributing to a deeper understanding of the molecular mechanisms underpinning this disease.
Conclusion
Ronald Reiter's innovative work in the field of breast cancer diagnosis and treatment is a testament to his dedication as an inventor. His research not only advances our understanding of cancer biology but also paves the way for potential therapeutic strategies that could improve patient outcomes in breast cancer treatment.